Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview
03/01/2025 11:03
* Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected
to show a
rise in quarterly revenue when it reports results on January 6
(estimated) for the period ending December 31 2024
* The Solana Beach California-based company is expected to
report
a 20.8% increase in revenue to $8.23 million from $6.81 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Clearpoint Neuro Inc is
for a
loss of 16 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $17.00, above its last closing price of $15.54.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2024 -0.19 -0.17 -0.18 Missed -3.8
Jun. 30 2024 -0.19 -0.20 -0.16 Beat 18.6
Mar. 31 2024 -0.18 -0.19 -0.16 Beat 15.8
Dec. 31 2023 -0.18 -0.20 -0.19 Beat 6.6
Sep. -0.25 -0.25 -0.20 Beat 20
30 2023
Jun. 30 2023 -0.19 -0.19 -0.29 Missed -52.6
Mar. 31 2023 -0.18 -0.18 -0.23 Missed -24.3
Dec. 31 2022 -0.20 -0.20 -0.18 Beat 10
This summary was machine generated January 3 at 11:03 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)